Calcium channel blockers reverse muscle weakness in animal model of myotonic dystrophy type 1

New research has identified the specific biological mechanism behind the muscle dysfunction found in myotonic dystrophy type 1 (DM1) and further shows that calcium channel blockers can reverse these symptoms in animal models of the disease.

Back to school for biotech, Biogen’s potential pivot, & Illumina’s next chapter

Are there still too many biotech companies? How do you know when you’re in a bubble? And is there a wrong way to pronounce “TIGIT”?

September 7, 2023

FDA’s lab developed test rule could be first check on agency’s power post-Chevron

The recent landmark U.S. Supreme Court decision to overturn the Chevron doctrine could open the door to more challenges of Food and Drug Administration regulations,

July 11, 2024

Sino Biological concludes SignalChem acquisition for $48m

Share this article The merger is expected to deliver a wider range of products and services to the life sciences community. Credit: Gorodenkoff/Shutterstock.com. Sino Biological

April 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.